2023 ISPE Biotechnology Conference

Featured Speakers


The 2023 ISPE Biotechnology Conference in Dublin from 26-27 June 2023, will give an overall view of the development and manufacturing of biotechnology products.

For the current originator pharmaceuticals, like mABs or vaccines, the challenges to increase productivity, process intensification, flexibility, and agility are distinctive when it comes to mass production. The conference will present and discuss modular facility design and collaborative project delivery.

The focus is on different challenges for innovative, biosimilar, and follow-up biotechnology products, like cell and gene therapy, Advanced Therapeutic Medicinal Products (ATMPs), and mRNA-based products - such as vaccines. The conference will feature presentations with a focus on time to market, shortened submission approval times, product transfer, new concepts for control strategy, quality oversight, manufacturing, and logistics.

The 2023 ISPE Biotechnology Conference will focus on the overarching themes that represent learnings from the originator pharmaceutical products that can be applied and transferred to the (new) biosimilar and follow-up biotechnology products. Methodological enablers for process development, supply chain resiliency, and more critically, driven by the energy crisis, sustainability will be the primary focus of our event. Discussions will be presented and considered within the current regulatory framework.

The conference will provide a leading interdisciplinary platform for all stakeholders of the pharmaceutical and biopharmaceutical value chain to present recent innovations and trends, and openly discuss practical challenges and solutions, from a technical, logistical, and regulatory perspective.

The impact of the evolving regulatory environment and the need to ensure continued innovation and continuity of the supply chain, considering the current energy crisis and assuring preparedness for future crises, will be integrated throughout the conference programme and panel discussions. Participants will have the opportunity to engage with industry leaders, regulators, and peers through networking events and the conference programme.


  • How to prepare successful Biopharmaceutical Operations
  • How to unlock opportunities given by Digitisation
  • Learn from Covid-19 challenges and resiliency

Featured Topics 

  • Road Mapping Digital Transformation in the Biotech Industry
  • Resiliency and Sustainability in Supply Chains
  • ATMPs/C&GTs: From Concept to Commercialisation
  • Applications of mRNA Technologies
  • Product Lifecycle Innovation through Cross-Fertilising Methodological Enablers across Gen 1 and Gen 2 products
  • When Speed to Market Counts: Exploring the Promising Future of Agile Manufacturing, Modular Facility Design, and Collaborative Project Delivery

Conference Highlight

Receive Notifications

Stay up-to-date on registration, education opportunities, speakers, hotel discounts, exhibitor information, and more by signing up to receive notifications for the 2023 ISPE Biotechnology Conference.

Company Type

Program Committee

Liz M. Dooley, MSc.
Senior Director - Engineering & Technology, Manufacturing Technical Operations
Janssen Sciences Ireland UC
Vivianne J. Arencibia
Vice President, Global Quality Systems and Compliance
Board Liaison
Laura-Ann Shaa Ling Chin, BSc, MSc, PE
Director, Life Sciences
Barry-Wehmiller Design Group
Placeholder Person Graphic
Aoife Catherine Corcoran
Associate Scientist
Janssen Biologics (Ireland)
Richard Denk
Senior Consultant Aseptic Processing & Containment
David Doleski
Head of Global Quality Audit and External Engagement
Jean-Francois Duliere
Pharmaceutical Senior Expert, Vice Chair ISPE France Affiliate
Prudence Edwards
Operational Excellence Specialist
Thermo Fisher Scientific Brisbane, Australia
Ylva Ek
Robur Life Science Advisory AB
David Estape, PhD
Senior Fellow - Biopharmaceutical Process
CRB Group
Anne Hayes
Inspection Manager, Compliance and PIC/S Chair
Christoph Herwig, PhD
Vienna University of Technology
Stephan Huelber
Process Engineer
VTU Engineering GmbH
Eamon P. Judge
Senior Director - Global Engineering
Eli Lilly And Company
Antonio R. Moreira, PhD
Vice Provost, Academic Affairs
University of Maryland
Foundation Board Liaison
Karine Peron
Head of Global Operations - Field Services and Validation Services
Merck Millipore
Phillip R. Smith, PhD
Director, Process Technology